Circassia Pharmaceuticals Share Price (CIR)

37.43 -0.45 (-1.17%) delayed: 10:06AM GMT
Bid price 37.00 Open price 0.00
Ask price 37.85 Prev close 37.88
High price 0.00 Spread 2.25%
Low price 0.00 Volume 0

Register now for FREE live Circassia Pharmaceuticals share prices, Circassia Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Circassia Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Circassia Pharmaceuticals (CIR) and other London Stock Exchange equities.

Circassia Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Circassia Pharmaceuticals share price charts

Circassia Pharmaceuticals Share Price Information

Name Circassia Pharmaceuticals Epic CIR
Sector Pharmaceuticals & Biotechnology ISIN GB00BJVD3B28
Activites Circassia Pharmaceuticals plc is a world-class specialty pharmaceutical business focused on respiratory disease. In addition to its market-leading NIOX products, the Company recently established a collaboration with AstraZeneca in the US in which it promotes the chronic obstructive pulmonary disease (COPD) treatment Tudorza, and has the US commercial rights to late-stage COPD product Duaklir. Circassia's development pipeline includes a range of respiratory medicines. The Company's lead asthma treatment targets substitution of GSK's Flixotide pMDI and was approved in the UK. Circassia is also developing a direct substitute for Seretide pMDI, and its pipeline includes a number of inhaled medicines for COPD, including single and combination dose products. Index n/a

Circassia Pharmaceuticals Key Numbers

Latest Share Price (p) 37.43 Net Gearing (%) 33.08
Market Capitalisation (£m) 142.45 Gross Gearing (%) 44.14
Shares in issue (m) 374.86 Debt Ratio 39.51
P/E Ratio -1.23 Debt-to-Equity Ratio 0.83
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.79
Dividend Yield (%) 0.00 Price to book value 0.63
Dividend cover (x) 0.00 ROCE (%) -30.57
Earning per share (p) -31.00 EPS Growth (%) 35.42
52 week high / low 98.90 / 36.00 DPS Growth (%) n/a

Circassia Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
17/07/2017 EXR Steven Harris CEO 535,375
18/09/2015 SELL Charles Swingland RES 1,230,000
18/09/2015 SELL Charles Swingland RES 9,000
18/09/2015 SELL Charles Swingland RES 754,548
27/03/2014 EXR Dr Rod Hafner ED 212,375

More Circassia Pharmaceuticals Director Deals >>

Circassia Pharmaceuticals Company News

17:17 11/02/2019

Holding(s) in Company

RNS Number : 6894P Circassia Pharmaceuticals Plc 11 February 2019            TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if...

09:00 08/02/2019

Notice of Results

RNS Number : 4320P Circassia Pharmaceuticals Plc 08 February 2019   8 February 2019     Circassia Pharmaceuticals plc   Notice of Preliminary Results     Circassia Pharmaceuticals plc (LSE: CIR) will announce its preliminary results for the...

16:44 06/02/2019

Holding(s) in Company

RNS Number : 2995P Circassia Pharmaceuticals Plc 06 February 2019   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i...

More Circassia Pharmaceuticals Company News >>

Register now for FREE Circassia Pharmaceuticals company news

Circassia Pharmaceuticals Share Price Discussions

No Circassia Pharmaceuticals Share Price Discussions

Register now for FREE Circassia Pharmaceuticals share price discussions